NCT03414177

Brief Summary

This study will conduct a 12-month randomized trial with 48 pediatric patients (aged 6-18 years) with persistent asthma to compare outcomes among patients with follow-up visits managed via telemedicine (TM) vs. in-person (IP) visits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 29, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

March 6, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

1.4 years

First QC Date

January 9, 2018

Last Update Submit

October 6, 2020

Conditions

Keywords

TelemedicineClinical follow up visits

Outcome Measures

Primary Outcomes (1)

  • Mean difference in ACT score at the final assessment (12 months) after adjusting for baseline

    ACT is used for symptoms monitoring as per guidelines and has been identified as an appropriate asthma control composite score in clinical research.

    At baseline and 12 months

Secondary Outcomes (8)

  • Routine Follow up Asthma Visit

    At baseline, 4 months, 8 months, 12 months

  • Lung Function via Spirometry

    Baseline and 12 months

  • Airway Inflammation via Spirometry

    Baseline and 12 months

  • Healthcare Utilization

    At baseline, 4 months, 8 months, 12 months

  • Medication Adherence

    At baseline, 4 months, 8 months, 12 months

  • +3 more secondary outcomes

Study Arms (2)

Telemedicine Group

ACTIVE COMPARATOR

Telemedicine participants will have asthma subspecialty follow-up visits conducted via real-time audio and video conferencing in conjunction with electronic examination peripherals and remote pulmonary function testing (PFT). Participants will receive a survey link to complete an electronic survey to assess Asthma Control Test (ACT) score, healthcare utilization, and satisfaction.

Other: Asthma Subspecialty Follow-up Visits

In-Person Group

ACTIVE COMPARATOR

In-Person participants will have asthma subspecialty follow-up visits at a subspecialty clinic. They will receive pulmonary function testing (PFT). Participants will receive a survey link to complete an electronic survey to assess Asthma Control Test (ACT) score, healthcare utilization, and satisfaction.

Other: Asthma Subspecialty Follow-up Visits

Interventions

Pediatric patients with persistent asthma will be recruited to compare outcomes among patients with follow-up visits managed via telemedicine vs. in-person visits.

In-Person GroupTelemedicine Group

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • age ≥6- and ≤18 years
  • persistent asthma as defined by national guidelines standards
  • receives care at an ACH asthma subspecialty clinic
  • reside ≤1.5 hour drive from Jonesboro, Springdale, Texarkana, or Fort Smith, AR

You may not qualify if:

  • Significant underlying respiratory disease other than asthma, such as cystic fibrosis
  • significant co-morbid conditions, such as individuals with developmental or physical impairments that could interfere with the ability to communicate via interactive video
  • current smoker
  • severe asthma exacerbation requiring intubation in the past 12 months
  • no access to a smartphone or internet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arkansas Children's Hospital Research Institute

Little Rock, Arkansas, 72202, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Tamara T. Perry, MD

    Arkansas Children's Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One group will receive asthma follow up care via telemedicine at a remote clinical sites. The second group will receive in-person asthma follow-up care at a specialty clinic.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2018

First Posted

January 29, 2018

Study Start

March 6, 2018

Primary Completion

August 8, 2019

Study Completion

October 1, 2019

Last Updated

October 8, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations